I'm revisiting TAKEDA - AMGEN alliance for Omontys!
Just google and find out,
takeda amgen alliance you will see numerous Billion $ alliances from 2008 onwards.
FMS not advancing the Pilot project even though it was effective ( based on Tom's article) and withdrawing the drug voluntarily from the Market place, AMGN's lowering of prices below their cost to up their ante for Omontys and winding down of AFFY.
If one look at these events, it looks to me with Roche's Mercera coming into market place in 2014 or so and AMGN's patents going away during this period, AMGN needs something in this arena to shore up their fortunes.
With AFFY management in place, it would be extremely difficult to wind down their stuff, rather a shock and awe, dismiss all their operations and takeover the drug and partner with AMGN to relaunch the drug successfully and keeping the royalty structure in place.
I'm pretty sure lots of things going on behind the scenes and I'm very positive on any possible outcomes.